Cargando…
Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial
BACKGROUND: Marfan syndrome (MFS) is one of the most common systemic disorders of connective tissue with the incidence of approximately 2-3 per 10 000 individuals. Aortic disease, leading to progressive aneurysmal dilatation and dissection is the main cause of morbidity and mortality of Marfan patie...
Autores principales: | Radonic, Teodora, de Witte, Piet, Baars, Marieke JH, Zwinderman, Aeilko H, Mulder, Barbara JM, Groenink, Maarten |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829559/ https://www.ncbi.nlm.nih.gov/pubmed/20067609 http://dx.doi.org/10.1186/1745-6215-11-3 |
Ejemplares similares
-
Inflammation Aggravates Disease Severity in Marfan Syndrome Patients
por: Radonic, Teodora, et al.
Publicado: (2012) -
No Beneficial Effect of General and Specific Anti-Inflammatory Therapies on Aortic Dilatation in Marfan Mice
por: Franken, Romy, et al.
Publicado: (2014) -
Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial
por: van Andel, Mitzi M, et al.
Publicado: (2020) -
The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients–Insights from Rodent-Based Animal Studies
por: van Andel, Mitzi M., et al.
Publicado: (2019) -
Mental Quality of Life Is Related to a Cytokine Genetic Pathway
por: Schoormans, Dounya, et al.
Publicado: (2012)